Prostate Cancer Screening in Sherman, TX at DFWPMA

Looking for prostate cancer screening in Sherman? At DFW Physicians Medical Associates (DFWPMA), our family medicine and primary care providers offer men’s preventive healthcare, including prostate cancer risk evaluations and consultations about prostate-specific antigen (PSA) testing to help patients make informed decisions about screening.

Prostate cancer screening typically involves a PSA blood test, which measures prostate-specific antigen levels to help identify possible prostate abnormalities before symptoms develop. An elevated PSA result does not necessarily indicate cancer, and further medical evaluation may be necessary to understand its cause.

Whether you’re considering your first PSA test, discussing previous screening results, or concerned about a family history of prostate cancer, DFWPMA Sherman provides individualized primary care evaluations to help determine whether screening is appropriate based on your age, medical history, personal risk factors, and preferences.

Book an appointment online or call (903) 957-0082 to contact our Sherman location.

Address: 📍
425 N Highland Ave., Suite 260, Sherman, TX 75092

Click here to get directions

We accept many major insurance plans. Not sure if your plan is accepted?

Call (903) 957-0082 and our team can help verify coverage.

Why Choose DFWPMA for Prostate Cancer Screening in Sherman?

DFW Physicians Medical Associates provides preventive men’s healthcare in Sherman through family medicine and primary care providers experienced in adult medicine, preventive screenings, chronic disease management, individualized medical evaluations, and comprehensive healthcare services.

Patients considering prostate cancer screening at DFWPMA Sherman can benefit from:

  • Experienced Primary Care Providers: Access to Dr. Ayodya Perera and Aniwelyn Tan, DNP, whose clinical backgrounds include preventive medicine, comprehensive primary care, and individualized adult healthcare evaluations.
  • Individualized Prostate Cancer Risk Assessment: Review of age, family history, previous PSA measurements, and personal health factors to determine whether prostate cancer screening discussions are appropriate.
  • Preventive Men’s Healthcare: Comprehensive medical assessments addressing prostate health, chronic medical conditions, and other recommended preventive services.
  • PSA Screening Guidance: Education about prostate-specific antigen testing, potential benefits, limitations, and possible implications of abnormal results.
  • Abnormal PSA Result Evaluation: Medical review of elevated PSA measurements and guidance regarding repeat testing, additional assessment, or urology referrals when appropriate.
  • Shared Medical Decision-Making: Individualized discussions about screening recommendations, patient preferences, false-positive findings, and the potential risks of unnecessary diagnostic procedures.
  • Coordinated Men’s Healthcare: Primary care evaluations and specialist referrals when further prostate assessment or diagnostic testing is clinically indicated.

Prostate cancer screening requires thoughtful consideration because PSA testing may identify clinically important cancer but can also detect abnormalities that would never cause symptoms. Decisions about screening should reflect individual risk, potential benefits and harms, and informed patient preferences rather than automatic annual testing.

Schedule an appointment with DFWPMA Sherman to discuss prostate cancer screening and your preventive men’s healthcare needs.

Meet Our Prostate Cancer Screening Providers in Sherman

Dr. Ayodya Perera, MD

Dr. Ayodya Perera is a family medicine physician providing comprehensive primary care and preventive healthcare for adolescents and adults ages 15 and older. She earned her medical degree from Tbilisi State Medical University and completed her Family Medicine Residency through New York Medical College at Hoboken University Hospital. Her clinical interests include preventive screenings, chronic disease management, weight management, and individualized primary care.

Dr. Perera’s experience in family medicine and preventive healthcare supports prostate cancer risk assessments, discussions about PSA screening, and evaluation of men’s health concerns. She emphasizes patient education and shared decision-making, helping patients understand screening recommendations, consider individual risk factors, and determine whether additional testing or specialist evaluation is appropriate.

Aniwelyn Tan, DNP

Aniwelyn Tan is a family nurse practitioner and primary care provider with more than 20 years of clinical experience. Her background includes cardiovascular intensive care nursing at Baylor Scott & White Hospital in Plano, along with experience in comprehensive medical care and chronic disease management. She holds Family Nurse Practitioner certification and Cardiovascular Nurse Practitioner Board Certification.

Her experience in primary care supports preventive men’s health evaluations, prostate cancer risk assessment, and individualized PSA screening discussions for patients ages 15 and older. Tan emphasizes comprehensive medical evaluations, patient education, and coordinated care, helping patients understand screening recommendations and arrange additional diagnostic assessment or urology consultation when clinically appropriate.

Book an appointment online to inquire about prostate cancer screening evaluations and preventive men’s healthcare with our Sherman primary care providers.

What Can Prostate Cancer Screening in Sherman Help With?

Prostate cancer screening helps identify men who may need further evaluation for prostate cancer before symptoms appear. PSA testing measures a protein produced by prostate tissue, but elevated measurements cannot independently diagnose cancer. Screening decisions should consider potential early detection benefits alongside false-positive results, overdiagnosis, and unnecessary treatment.

At DFWPMA Sherman, prostate cancer screening evaluations and related preventive healthcare may help with:

  • Prostate Cancer Risk Assessment: Identifying personal and family history factors that may increase the likelihood of developing prostate cancer.
  • PSA Screening Evaluation: Determining whether prostate-specific antigen blood testing is appropriate after discussing potential benefits and harms.
  • Elevated PSA Level Assessment: Reviewing abnormal results that may be associated with prostate cancer, benign prostate enlargement, or prostate inflammation.
  • Routine Men’s Preventive Care: Incorporating prostate cancer risk discussions into age-appropriate primary care evaluations and preventive health visits.
  • Abnormal Screening Follow-Up: Evaluating previous PSA findings to determine whether repeat testing, additional assessment, or urology consultation is recommended.
  • Individualized Screening Decisions: Considering age, family history, overall health, life expectancy, and patient preferences when discussing prostate cancer screening.

According to the U.S. Preventive Services Task Force (USPSTF), its current final recommendation supports individualized decisions about PSA-based prostate cancer screening for men ages 55–69 after discussing potential benefits and harms with a clinician. The USPSTF recommends against routine PSA-based screening for men ages 70 and older.

These recommendations apply to men without prostate cancer symptoms or a previous prostate cancer diagnosis. Men with a family history of prostate cancer or other elevated risk factors may benefit from earlier screening discussions, although evidence supporting routine PSA testing before age 55 remains limited under the USPSTF recommendation.

A PSA blood test cannot confirm prostate cancer. Elevated levels may result from benign prostatic hyperplasia, prostatitis, or other noncancerous conditions. Men experiencing urinary difficulties, blood in the urine, or other concerning symptoms require diagnostic evaluation rather than relying solely on routine screening.

What Prostate Cancer Screening Services Are Available in Sherman?

Prostate cancer screening services generally involve evaluating individual cancer risk, discussing PSA blood testing, interpreting screening results, and determining whether additional medical evaluation is necessary. The appropriate approach depends on age, family history, previous PSA measurements, overall health, and informed patient preferences.

At DFWPMA Sherman, men’s preventive healthcare and prostate screening evaluations may include:

  • PSA Blood Testing Consultation: Assessing whether prostate-specific antigen testing is appropriate, with testing arrangements determined by clinical recommendations and service availability.
  • Prostate Cancer Risk Assessment: Reviewing age, family history, previous screening results, and medical factors influencing prostate cancer risk.
  • Screening Benefits and Risks Discussion: Explaining possible early detection benefits, false-positive findings, overdiagnosis, and potential consequences of additional diagnostic procedures.
  • Abnormal PSA Result Evaluation: Reviewing elevated or changing PSA measurements to determine whether repeat testing or specialist assessment is appropriate.
  • Preventive Men’s Health Visits: Comprehensive primary care evaluations addressing prostate health concerns, cardiovascular risk, chronic medical conditions, and other preventive healthcare needs.
  • Urology Referrals: Coordinating specialist evaluation when abnormal findings warrant additional testing, prostate imaging, or consideration of biopsy.
  • Screening Follow-Up and Education: Providing guidance about PSA results, appropriate reassessment intervals, individual risk factors, and recommended next steps.

During PSA screening, a healthcare professional collects a blood sample to measure prostate-specific antigen levels. The test itself involves a routine blood draw. A digital rectal examination may be considered selectively as part of a clinical assessment but is not recommended as a stand-alone prostate cancer screening test.

An elevated PSA result does not automatically indicate prostate cancer. According to the American Academy of Family Physicians (AAFP), abnormal PSA measurements should generally be repeated within a few months before proceeding to additional biomarkers, urology referral, biopsy, or imaging, depending on clinical circumstances.

Prostate cancer screening should follow evidence-based recommendations and individual medical history. Unnecessary testing may lead to false-positive results, avoidable biopsies, and treatment-related complications, while appropriate evaluation can help identify potentially significant prostate cancer in selected patients.

Looking for prostate cancer screening in Sherman? Contact DFWPMA at (903) 957-0082 or book an appointment online to schedule a preventive men’s healthcare appointment, discuss PSA testing availability, and review your individual prostate cancer screening options.